- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- October 2024
- 199 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 189 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- January 2025
- 270 Pages
Global
From €4789EUR$4,995USD£4,001GBP
- Report
- May 2024
- 213 Pages
Global
From €4789EUR$4,995USD£4,001GBP
- Report
- April 2019
- 153 Pages
Global
From €1318EUR$1,375USD£1,101GBP
€2636EUR$2,750USD£2,203GBP
- Report
- October 2023
- 140 Pages
North America
From €3835EUR$4,000USD£3,204GBP
- Report
- April 2023
- 181 Pages
Global
From €2397EUR$2,500USD£2,003GBP
- Book
- March 2020
- 281 Pages
- Book
- December 2022
- 1376 Pages
- Book
- April 2020
- 342 Pages

Nephropathy is a medical condition that affects the kidneys and is a major focus of Urology and Nephrology. It is caused by a variety of factors, including diabetes, hypertension, and glomerulonephritis. Symptoms of nephropathy can include proteinuria, edema, and hypertension. Treatment options vary depending on the cause and severity of the condition, but may include medications, lifestyle changes, and dialysis.
The nephropathy market is a rapidly growing sector of the Urology and Nephrology industry. It is driven by the increasing prevalence of chronic kidney diseases, as well as the development of new treatments and technologies. Companies in this market are focused on developing and marketing products and services to diagnose, treat, and manage nephropathy. Examples of companies in this market include Baxter International, Fresenius Medical Care, and DaVita. Show Less Read more